Literature DB >> 8548356

Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits.

E M O'Byrne1, D T Parker, E D Roberts, R L Goldberg, L J MacPherson, V Blancuzzi, D Wilson, H N Singh, R Ludewig, V S Ganu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8548356     DOI： 10.1007/bf01778290

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

1.  Morphometric quantitation of histopathologic changes in articular cartilage in an immunologically-induced rabbit model of rheumatoid arthritis.

Authors:  A S Rubin; E D Roberts
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

2.  Comparison of magnetic resonance imaging (MRI) and histopathology in rabbit models of osteoarthritis and immune arthritis.

Authors:  E M O'Byrne; P K Paul; E D Roberts; V Blancuzzi; D Wilson; R L Goldberg; G DiPasquale
Journal:  Agents Actions       Date:  1993

3.  Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.

Authors:  R A Greenwald; S A Moak; N S Ramamurthy; L M Golub
Journal:  J Rheumatol       Date:  1992-06       Impact factor: 4.666

4.  Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis.

Authors:  F Mehraban; S Y Kuo; H Riera; C Chang; R W Moskowitz
Journal:  Arthritis Rheum       Date:  1994-08

5.  A new model of osteoarthritis in rabbits. I. Development of knee joint pathology following lateral meniscectomy and section of the fibular collateral and sesamoid ligaments.

Authors:  C Colombo; M Butler; E O'Byrne; L Hickman; D Swartzendruber; M Selwyn; B Steinetz
Journal:  Arthritis Rheum       Date:  1983-07

6.  Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.

Authors:  D D Dean; J Martel-Pelletier; J P Pelletier; D S Howell; J F Woessner
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808
  6 in total
  2 in total

1.  Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers.

Authors:  A W Millar; P D Brown; J Moore; W A Galloway; A G Cornish; T J Lenehan; K P Lynch
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 2.  Comparison between in vitro and in vivo cartilage overloading studies based on a systematic literature review.

Authors:  Mieke Nickien; Ashley Heuijerjans; Keita Ito; Corrinus C van Donkelaar
Journal:  J Orthop Res       Date:  2018-04-12       Impact factor: 3.494
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.